-
Aug 26, 2025The Importance Of Administration Volume in Preclinical Studies | Prisys BiotechDiscover why administration volume is a critical factor in preclinical drug development. Learn how standardized dosing volumes improve safety, data reliability, and translationa... -
Aug 05, 2025Serum Vs. Plasma: Choosing The Optimal Matrix For Preclinical BioanalysisDiscover how to choose between serum and plasma for drug analysis in preclinical studies. Prisys Biotech explains the scientific and operational trade-offs critical to accurate,... -
Jul 31, 2025Preclinical Dosing Guidelines: IV & PO Volume, PH, And Osmolarity For Accurat...Ensure accuracy in preclinical PK studies with optimized IV and PO dosing volumes, pH, and osmolality across species. Learn how Prisys Biotech enhances drug delivery in NHP and ... -
Jul 10, 2025A Guide To Anti-Drug Antibody (ADA) AssessmentExplore ADA formation, risk factors, impact on PK/ADME, and advanced preclinical assessment strategies, including the TDAR assay offered by Prisys Biotech. -
Jun 26, 2025Key Considerations For Dosing Volume, PH, And Formulation in Animal ModelsLearn essential considerations for preclinical pharmacokinetic (PK) studies, including recommended dosing volumes, pH ranges, and formulation strategies for different animal spe... -
Jun 13, 2025Guiding Principles For Animal Species Selection in Nucleic Acid Drug Toxicolo...Explore key considerations for selecting appropriate animal species in non-clinical toxicology studies for nucleic acid drugs, focusing on on-target and off-target toxicity asse... -
May 23, 2025Designing Animal Studies: Key Considerations For Preclinical Research SuccessMaster the essentials of animal study design for impactful preclinical research. Explore scientific, ethical, and statistical principles, animal model selection, and data analys... -
Mar 28, 2025Nonclinical Immunotoxicity Assessment: Strategy, Key Considerations, And Meth...Expert guide to nonclinical immunotoxicity assessment: Explore Weight of Evidence (WoE) strategies, key concerns (immunosuppression, CRS, DIT), method selection, and the critica... -
Mar 25, 2025Microbial Testing And Its Impact On Non-Human Primates in Preclinical DMPK St...Explore the critical role of NHP microbial testing in preclinical DMPK studies for drug development. Learn how Prisys Biotech's stringent "five-negative monkey" standard and ani... -
Mar 04, 2025World Obesity Day | Prisys Biotech NHP Metabolic Models: Powering The Develop...Prisys Biotech offers advanced NHP metabolic models (obesity, diabetes, insulin resistance, hyperlipidemia, hypertension) to accelerate your anti-obesity drug discovery. AAALAC-... -
Feb 21, 2025Integration Of Pharmacokinetics And Pharmacodynamics in Drug DevelopmentTo explain the importance and applications of PK/PD integration in drug development, highlight key concepts, and emphasize the need for rigorous scientific analysis and interdis... -
Feb 18, 2025What Does Proof Of Concept (PoC) in Drug Development Really Validate?Explore the importance of Proof of Concept (PoC) in drug development, focusing on gene therapy. This article outlines the core objectives, implementation strategies, and success...
